TotalMarketCap

Evommune

EVMNNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$262.820 M

$6.37 +5.46%

Close of 6 Nov 2026

As of 6 Nov 2026, Evommune (EVMN) has a market capitalization of $262.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$13.0M

#3082 by revenue

Earnings

-$68.9M

Loss-making

Shares outstanding

36,292,113

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #228Q32 BioQTTB$265.1M
  2. #229ARS PharmaceuticalsSPRY$263.0M
  3. #230EvommuneEVMN$262.8M
  4. #231BioAge LabsBIOA$254.3M
  5. #232Larimar TherapeuticsLRMR$244.6M

What if Evommune were worth as much as…

Open the what-if tool →

Gold $28.2T

$684,380.92

Per share 107,438× higher

Bitcoin $1.53T

$37,030.66

Per share 5,813× higher

Apple $5.02T

$121,568.20

Per share 19,084× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Evommune are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.